Latest Cancer News

Investigational Drug Improves Outcomes among Prostate Cancer Patients with Bone Metastases (02-3-2012)
In a Phase III clinical trial, the investigational drug radium-223 chloride improved survival and delayed bone complications among men with hormone-refractory prostate cancer and bone metastases. These... Continue Reading

New Targeted Drug Improves Prostate Cancer Survival (02-2-2012)
Among men with metastatic, hormone-refractory prostate cancer, treatment with the investigational drug MDV3100 delayed cancer progression and improved overall survival. These results will be presented... Continue Reading

Erivedge Approved for Basal Cell Skin Cancer (02-1-2012)
The US Food and Drug Administration (FDA) has approved the targeted therapy Erivedge™ (vismodegib) for the treatment basal cell carcinoma of the skin that has spread to other parts of the body or that... Continue Reading

More Cancer News